APAC Digital Health Ecosystem 2023 Mid Year Report

The semi-annual report on Digital Health’s current state and future outlook, APAC H1 2023 Key Trends, is a must-read. It covers private ventures and includes information on ecosystem development, active partners, venture funding, and current trends. Europe has emerged as a focused and mature ecosystem, securing the top spot globally for ventures with Clinical Evidence while taking second place in venture funding.

  • The lack of funding activity in South Asia and China has resulted in a 49% decrease in digital health venture funding in APAC. This trend is consistent across all sub-regions in Asia Pacific. South East Asia which saw a strong growth between 2021 and 2022 fell experienced a strong fall in the first half of the year.
  • Following the global trend, the number of partnerships announced by Digital Health ventures founded in Asia Pacific grew 1.9x YoY from 2021 to 2022. So far, 2023 has seen 1.7x more partnerships than the same period in 2022.
  • In H1 2023, 38 ventures in Asia Pacific achieved a total of 50 regulatory filings. The, Asia Pacific region is slowly losing share of global regulatory filings, capturing 23% of the H1 2023 global filings compared to 28% in 2020.
  • Health Management Solutions received the most funding among digital health clusters, thanks to a $59M funding round for Japan’s KAKEHASHI. Research Solutions, on the other hand, dropped from 1st to 5th place compared to last year.
  • China and India are the most affected sub-regions in Asia Pacific, with declines in both funding volume and value. India’s previously thriving digital health ecosystem has experienced setbacks, including the IPO withdrawal of Pharmeasy. China’s stringent policies and slower-than-expected economic recovery have hampered digital health funding so far this year.

Countries included in the analysis: China, India, Hong Kong, Singapore, Japan, South Korea, Australia, Vietnam, Thailand, Indonesia, Pakistan, Taiwan, Malaysia, New Zealand, Myanmar, Sri Lanka, Philippines, Cambodia and Bangladesh

The “Asia Pacific Digital Health Innovation Ecosystem Report on H1 2023 Key Trends” report includes data on the following companies: UNIMED, Medii, Dr. Diary, Provigate, Wise Healthcare, KAKEHASHI, Saluda Medical, Thorough Images, BuyMed, TandemAI, S-Alpha Therapeutics, Holmusk, HealthifyMe, Mindset Health, HealthPlix, Eaglenos, Triple W, Dozee, Neurosensum, Hacarus, Care, Eucalyptus, EOFlow, XtalPi, Smartabase, CNSDose, Pierian, Medtronic, Lilly, Teamworks, Incite Health, Summa Equity, Pfizer, Fosun Pharma, Selgate Healthcare, Hitachi, Gero, WeDoctor, Doc2Us, Cyfuse Biomedical,

HealthTech Alpha, a Galen Growth proprietary solution, powers this report!

About our Premium Reports

Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.

Source of Data

Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.

Our Mission

Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com

ABOUT GALEN GROWTH  
HEADLINES: 9 pages, 7 charts, 5 tables  
ECOSYSTEM INSIGHTS: 5 pages, 7 charts, 2 tables  
INVESTMENT INSIGHTS: 7 pages, 22 charts  
CLUSTER FOCUS: 4 pages, 2 charts, 1 table  
THERAPEUTIC FOCUS: 3 pages, 2 charts, 1 table  
DEEP DIVES: 21 pages, 24 charts, 4 tables  
NOTEWORTHY: 4 pages, 3 tables  
KEY INFORMATION  

Buy Only

BASIC

  • Purchase and download this report
  • Access to limited data in HealthTech Alpha
$499.00
Buy Now
Recommended

PRO

  • Sign up now to download all premium research
  • Access and download all data in HealthTech Alpha
$ 385 /Month
Pro
Custom Solution

Enterprise

  • Get full access to unmatched premium research for your organization
  • Additional collaboration features to take your team's research and collaboration to the next level
Let's Talk
Contact Us

© Galen Growth 2024

Overview

Category

Stage

Total Funding

GGA Score

powered by